| US Medicare to revisit coverage of anemia drugs - Reuters UK |
|
|
Reuters UKRBC has already projected a 25 percent decline in sales of Amgen's Epogen from 2011 to 2013, due mostly to a plan by CMS to "bundle" payments for dialysis ... read more |